Bishoy Faltas, MD

September 17, 2014

August 19, 2014

A new study found a high rate of peripheral neuropathy in antiretroviral-naive patients within 3 months after HIV infection.

August 19, 2014

The largest record linkage study to examine an association between the diseases could open inquiry into a protective effect greater than any factor yet observed for development of MS.

August 18, 2014

A recent study found that coinfection with cytomegalovirus and HIV was an independent risk factor for cerebrovascular and cardiovascular events.

July 05, 2014

Antiretroviral therapy has greatly reduced the incidence of non-Hodgkin lymphoma. But, a new study finds the risk is still high even at low levels of HIV infection.

June 18, 2014

Asymptomatic neurocognitive impairment is common among HIV-infected patients. Can it be used to predict future cognitive decline? New research answers the question.

June 17, 2014

A recent study examined the improvement in life expectancy associated with CD4+ cell count response and viral suppression status in patients on combination antiretroviral therapy.

June 17, 2014

With the advent of powerful antiretroviral therapies, rates of pulmonary malignancy have declined in HIV-infected patients. But, say results of a new study, we can’t take malignant causes out of the differential yet.

June 05, 2014

Chemotherapy-induced peripheral neuropathy affects approximately 40% of adult cancer survivors. But, new evidence-based guidelines on prevention and management of the condition find very few effective therapies.

May 19, 2014

The increased risk was independent of potential confounders such as fracture history, alcohol abuse, or use of drugs such as corticosteroids.